Literature DB >> 6190888

Metronidazole need not be combined with an aminoglycoside when used for prophylaxis in elective colorectal surgery.

D L Morris, M M Hares, R J Voogt, D W Burdon, M R Keighley.   

Abstract

A prospective randomized controlled study has compared prophylactic intravenous metronidazole alone with the combination of metronidazole and gentamicin in 100 patients having elective colorectal surgery. There was no significant difference in mortality, infection, dehiscence or postoperative stay between the antibiotic groups. Postoperative sepsis was almost entirely due to aerobic organisms but was associated with minimal morbidity. A significantly higher rate of anastomotic dehiscence and postoperative infection was seen where the quality of bowel preparation was judged to be poor.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6190888     DOI: 10.1016/0195-6701(83)90067-1

Source DB:  PubMed          Journal:  J Hosp Infect        ISSN: 0195-6701            Impact factor:   3.926


  4 in total

1.  Reduction of experimental wound infection rate by administration of clindamycin in addition to netilmicin.

Authors:  F Moesgaard; M C Lykkegaard Nielsen; P N Larsen; M Tvede
Journal:  Eur J Clin Microbiol       Date:  1986-08       Impact factor: 3.267

2.  Assessing the problem, preparing the patient, and minimizing the risks in rectal cancer surgery.

Authors:  J Alexander-Williams; M R Keighley
Journal:  World J Surg       Date:  1982-09       Impact factor: 3.352

3.  Biogenesis of Fungal Extracellular Vesicles: What Do We Know?

Authors:  Haroldo C de Oliveira; Amanda F Kato; Bianca A G Sena; Iraine Duarte; Luísa J Jozefowicz; Rafael F Castelli; Diogo Kuczera; Flavia C G Reis; Lysangela Ronalte Alves; Marcio L Rodrigues
Journal:  Curr Top Microbiol Immunol       Date:  2021       Impact factor: 4.291

4.  Fungal Extracellular Vesicles as a Potential Strategy for Vaccine Development.

Authors:  Leandro Honorato; Jhon Jhamilton Artunduaga Bonilla; Alicia C Piffer; Leonardo Nimrichter
Journal:  Curr Top Microbiol Immunol       Date:  2021       Impact factor: 4.291

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.